✦ LIBER ✦

CPT-11 and L-OHP combination versus alternated combination of LV5FU2 + CPT-11/LV5FU2 + L-OHP in 5-FU resistant advanced colorectal cancer (CRC): Preliminary results

✍ Scribed by Y. Becouarn; M. Mousseau; E. Gamelin; B. Coudert; J. Marceau-suissa; M. Bekradda

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oxaliplatin (L-OHP) in combination with

✍ G.D. Beretta; S. Cascinu; A. Zaniboni; R. Ratti; P. Giordani; V. Catalano; G. Ma 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 116 KB

756 - Phase I/II study of CPT-11 in comb

✍ Ph. Rougler; M. Ychou; J.F. Seitz; M. Bonnay; D. Mignard; C. Couteau; J.P. Arman 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 260 KB

A phase II study of leucovorin (LV)-modu

✍ Aschele, A.; Lonardi, S.; Sartor, L.; Perin, A.; Koussis, B.; Nicoletto, O.; Mon 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 194 KB

A phase II study of irinotecan (CPT-11)

✍ Rosati, G.; Tucci, A.; Rinaldi, A.; Colarusso, D.; Rossi, A.; Pizza, C.; Manzion 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase II study of alternating cycles o

✍ G. Rosati; D. Bilancia; S. De Santis; A. Dinota; A. Rossi; L. Manzione 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Bifractionated CPT-11 with LV5FU2 infusi

✍ Kim, Stefano; Dobi, Erion; Jary, Marine; Monnien, Franck; Curtit, Elsa; NGuyen, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 235 KB